Extension Study Evaluating The Safety And Tolerability of AMX0035

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT05619783

Recruitment Status : Enrolling by invitation

First Posted : November 17, 2022

Last Update Posted : January 5, 2024

View this study on the modernized ClinicalTrials.gov

Sponsor:

Information provided by (Responsible Party):

Amylyx Pharmaceuticals Inc.

Study Details
Tabular View
No Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Enrolling by invitation
Estimated Primary Completion Date :	March 2026
Estimated Study Completion Date :	August 2026

To Top